Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bluebird Bio
Biotech
BIO, Seaport, Orna and more—Chutes & Ladders
Top BIO lobbyist swiftly departs after BIOSECURE reversal. Karuna leaders launch new venture after BMS buyout. Orna snags top Kite exec as CMO.
Max Bayer
,
Gabrielle Masson
Apr 12, 2024 8:30am
Ex-bluebird execs hope to fly startup to delivery tech heights
Apr 9, 2024 7:00am
ASH: Editas shares data for mid-stage sickle cell disease asset
Dec 11, 2023 2:33pm
Bluebird closer to lovo-cel approval after FDA smooths path
Aug 16, 2023 9:59am
New year, new C-suite execs—Chutes & Ladders
Jan 6, 2023 9:30am
Bluebird's sickle cell trial in under-18s back after year hold
Dec 19, 2022 10:55am